Tru-D SmartUVC to Exhibit at Premier Annual Breakthroughs Conference
Tru-D SmartUVC will join members of Premier at the Premier Annual Breakthroughs Conference and Exhibition in Washington, DC, June 27-30, 2017. Tru-D invites attendees to visit its booth #639 to learn about its cutting-edge technology that was recently validated by the only randomized clinical trial on UV disinfection.
Premier is a health care improvement company uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provider organizations. As an industry leader, Premier has created one of the most comprehensive databases of actionable data, clinical best practices and efficiency improvement strategies. Tru-D has been a contracted supplier with Premier since 2014.
“Tru-D partners with health care facilities and hospital systems nationwide to reduce costly hospital-acquired infections while also saving on the bottom line through purchasing organizations such as Premier,” said Chuck Dunn, CEO and president of Tru-D SmartUVC. “Our team looks forward to attending Premier Breakthroughs and demonstrating how Tru-D can provide a significant ROI while minimally impacting productivity.”
Tru-D, short for “total room ultraviolet disinfection,” is rolled in a hospital room after the environmental services staff cleans using traditional protocols. Used as an enhanced terminal room disinfection strategy, Tru-D is then activated by a remote control and begins administering a lethal cycle of UVC energy. Operating from a single placement in the room, Tru-D provides thorough room disinfection, killing up to 99.9 percent of harmful pathogens that can remain behind such as C. diff, MRSA, MERS, VRE, Ebola and many more. While the cycle is being completed, operators are free to tend to other tasks and are alerted via audio and/or text message when disinfection is complete.
“When evaluating various UV disinfection robots, it is important to consider total room disinfection versus partial room disinfection,” said Dunn. “Tru-D’s patented Sensor360 technology is able to compensate for room variables such as size, shape and contents to deliver the precise, lethal dose of UVC energy needed in each unique space.”
Tru-D was the only device of its kind selected for the first-ever randomized, clinical trial on UVC disinfection because of its Sensor360 technology that eliminates any chance of human error in the disinfection process. Results of the landmark Benefits of Enhanced Terminal Room Disinfection (BETR-D) study proved that enhanced terminal room disinfection strategies that utilized Tru-D decreased the relative risk of acquisition and infection of multidrug-resistant organisms by a cumulative 30 percent among patients admitted to the same room when 93 percent compliance was achieved.
Individual hospital results may vary based on numerous factors including adherence to standard disinfection protocol.
Tru-D invites attendees to their booth #639 to learn more about the gold standard in UV disinfection.